Publication | Closed Access

Artificial intelligence–powered programmed death ligand 1 analyser reduces interobserver variation in tumour proportion score for non–small cell lung cancer with better prediction of immunotherapy response

Immunotherapy ResponseBetter PredictionPrognostic BiomarkersOncologyMedicineImmunologyTumor ImmunityCancer GenomicsImmune SurveillanceMolecular DiagnosticsRadiation OncologyLung CancerCancer ResearchTumour Proportion ScoreComputational Medicine